Review
[Pharmacological treatment of acromegaly]
[Article in
Spanish]
Affiliations
- PMID: 17022308
Item in Clipboard
Review
[Pharmacological treatment of acromegaly]
[Article in
Spanish]
Gac Med Mex.
2006 Jul-Aug.
Abstract
Acromegaly is an endocrine disorder usually due to a growth hormone (GH)-secreting pituitary adenoma. This deforming disease is associated with several metabolic abnormalities and results in an elevated cardiovascular mortality. Pituitary transsesphenoidal surgery has been considered the treatment of choice, however, even in the most experienced hands this procedure succeeds in curing only 50 to 60% of the patients. Therefore, close to 50% of patients require an adjunctive form of treatment such as radiation therapy or the use of diverse medications that modulate GH secretion (somatostatin analogues) or action (GH receptor antagonists). The present review summarizes the clinical experience with these novel medications.
Similar articles
-
Drug insight: Primary medical therapy of acromegaly.Nat Clin Pract Endocrinol Metab. 2006 Feb;2(2):109-17; quiz following 117. doi: 10.1038/ncpendmet0096. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932265 Review.
-
Pharmacological options in the treatment of acromegaly.Curr Opin Investig Drugs. 2005 Oct;6(10):1023-7. Curr Opin Investig Drugs. 2005. PMID: 16259223 Review.
-
An update on treatment strategies for acromegaly.Expert Opin Pharmacother. 2008 Sep;9(13):2273-80. doi: 10.1517/14656566.9.13.2273. Expert Opin Pharmacother. 2008. PMID: 18710352 Review.
-
Pharmacological therapy for acromegaly: a critical review.Drugs. 2004;64(16):1817-38. doi: 10.2165/00003495-200464160-00007. Drugs. 2004. PMID: 15301564 Review.
-
[Advances in the treatment of acromegaly].Pol Merkur Lekarski. 2008 Jan;24(139):59-65. Pol Merkur Lekarski. 2008. PMID: 18634256 Review. Polish.